E09.620
Drug or chemical induced diabetes mellitus with diabetic dermatitis
Clinical Classification Guidelines
Inclusion Terms
- Drug or chemical induced diabetes mellitus with diabetic necrobiosis lipoidica
Medical Intelligence & Overview
ICD-10 code E09.620 refers to a type of diabetes caused by drugs or chemicals, which also presents with diabetic dermatitis. This condition occurs when certain medications or chemicals interfere with the body's ability to regulate blood sugar levels, leading to diabetes that is associated with specific skin conditions. Patients might notice skin changes such as lesions or ulcers, often linked to diabetic skin complications like necrobiosis lipoidica. Recognizing this condition is essential for appropriate management and treatment of both the underlying cause and its dermatological effects.
Causes & Symptoms
Clinical Causes: Use of specific medications such as diuretics, glucocorticoids, or antipsychotics Exposure to certain industrial chemicals or toxins Prolonged or high-dose use of drugs affecting blood sugar metabolism
Key Symptoms: Elevated blood glucose levels Skin lesions or plaques, often shiny and yellowish, typically on the shins Ulcers or wounds that heal slowly Itching or soreness in affected skin areas Signs of diabetic necrobiosis, including skin thinning or degenerative changes
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a review of the patient's medical history, medication use, and blood tests to confirm elevated blood sugar levels. Skin biopsy may be performed to assess characteristic changes in diabetic dermatitis, particularly necrobiosis lipoidica. Physicians also consider the timing of medication exposure and onset of symptoms to establish a link between drug use and diabetes development.
Treatment Protocols: Management includes discontinuing or replacing the offending medication under medical supervision. Controlling blood sugar levels through diet, medications, or insulin therapy is crucial. Treating skin lesions may involve topical medications to reduce inflammation and prevent infections. Regular monitoring of blood glucose and skin health helps prevent complications. In some cases, additional therapies such as laser treatment or corticosteroids may be recommended for skin lesions.
Clinical Advice & FAQs
Billing Guidance
Is E09.620 a billable ICD-10 code?
Yes, E09.620 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E09.620?
Clinical documentation must specify the nature of Drug or chemical induced diabetes mellitus with diabetic dermatitis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference